Saudi Arabia Healthcare Bioconvergence Market Research Report 2025, Competitive Analysis of Saudi Biotechnology Manufacturing, Lifera Omics, Amgen, Tamer Group, and Merck
The Saudi Arabia Healthcare Bioconvergence Market, valued at USD 550.33 Million in 2024, is projected to reach USD 1.14 Billion by 2030, growing at a CAGR of 4.42%. Technological innovations, including AI and robotics, along with increased R&D investments, fu…